test

Nathalie Auber

@Sofinnova Investments, Inc.

Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.

Assets under management

The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RAPPRapport Therapeutics Inc
Recent Activity
Increased 2.26%
3.25%
$40.87M
1.996M shares@ $20.48 avg price
AVBPArrivent Biopharma Inc
Recent Activity
3.17%
$39.874M
1.697M shares@ $23.5 avg price
YMABY-mabs Therapeutics Inc
Recent Activity
2.3%
$28.855M
2.194M shares@ $13.16 avg price
DYNDyne Therapeutics Inc
Recent Activity
Decreased -52.5%
2.21%
$27.733M
772,070 shares@ $35.92 avg price
COGTCogent Biosciences Inc
Recent Activity
Decreased -18.31%
1.95%
$24.464M
2.265M shares@ $10.8 avg price
SVRASavara Inc
Recent Activity
Increased 2.79%
1.91%
$24.009M
5.663M shares@ $4.24 avg price
NVSNovartis Ag
Recent Activity
New Position
1.83%
$23.004M↓ Put
200,000 shares@ $115.02 avg price
INZYInozyme Pharma Inc
Recent Activity
1.78%
$22.386M
4.28M shares@ $5.24 avg price
JAZZJazz Pharmaceuticals Plc
Recent Activity
New Position
1.67%
$21.008M
188,562 shares@ $111.41 avg price
INSMInsmed Inc
Recent Activity
Increased 25.72%
1.66%
$20.9M
286,307 shares@ $73.0 avg price